Today: 11 June 2026
Meta stock slides as “Meta Compute” plan spotlights AI spending and power risk

Meta stock slides as “Meta Compute” plan spotlights AI spending and power risk

NEW YORK, Jan 13, 2026, 09:36 EST — Regular session

Meta Platforms shares slipped 1.7% to roughly $642 in early New York trading Tuesday following CEO Mark Zuckerberg’s announcement of a new “Meta Compute” initiative aimed at expanding the company’s AI infrastructure. The wider market held firm, with the S&P 500 and Nasdaq indices edging up slightly.

The announcement comes as investors remain wary of hefty, long-term spending, even among mega-cap tech giants. Meta’s strategy hinges on scale — ramping up chips, data centers, and power — yet the market is still grappling with the timing and size of expected returns.

Meta is shaking up its leadership as it ramps up efforts in Washington and plans long-term investments in data centers and energy. On Monday, the company appointed Dina Powell McCormick—ex-Goldman Sachs exec and former Trump administration official—as president and vice chairman. Meta said she’ll focus on expanding data centers and forging strategic partnerships.

Zuckerberg announced that the “Meta Compute” initiative will be co-led by infrastructure chief Santosh Janardhan and Daniel Gross, who will oversee strategic capacity planning and partnerships. He noted on Threads that “Meta is planning to build tens of gigawatts this decade, and hundreds of gigawatts or more over time,” highlighting the massive power demand that could raise concerns in local communities. Reuters

Meta isn’t the only one zeroing in on power and water. On Tuesday, Microsoft unveiled a community-focused data center plan that promises better utility pricing and regional U.S. water-use transparency—highlighting just how closely these issues are being watched.

A recent securities filing dropped a familiar detail for traders. On Monday, Meta executive Javier Olivan filed a Form 144 revealing plans to sell up to 517 Class A shares. The sale is set to happen under a Rule 10b5-1 plan — a prearranged strategy designed to sidestep trading on inside information.

Still, execution and the bill pose the greater risks. Massive infrastructure projects often hit snags—power issues, permits, supply chain hiccups, and political hurdles. Margins could come under strain if ad growth falters or if AI products take longer to bring in revenue than investors anticipate.

Europe’s regulators are shaking things up again. Meta will carve out Italy from its upcoming ban on rival AI chatbots on WhatsApp, following a directive from Italy’s antitrust watchdog, a notice seen by Reuters reveals. The new WhatsApp terms, reflecting this carve-out, will kick in on Jan. 15. Marvin von Hagen, CEO of rival AI firm Poke.com, slammed the move, saying, “Meta should have suspended the policy worldwide, not just in Italy.” Reuters

Stock Market Today

  • Top Software Stocks Set for Rally in Second Half, Says BofA
    June 11, 2026, 11:15 AM EDT. Bank of America (BofA) has identified leading software stocks poised for a significant rally in the second half of the year. While specific companies were not detailed, BofA's outlook highlights growth potential in the tech sector amid evolving market conditions. Investors are closely watching software firms as demand for digital solutions continues to expand, driven by cloud computing and enterprise software trends. This bullish stance from a major financial institution underscores confidence in software stocks as key components of portfolio growth strategies moving forward.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
ZIM stock edges up in premarket after a 52-week high run — what traders watch next
Previous Story

ZIM stock edges up in premarket after a 52-week high run — what traders watch next

Dow Jones today: DJIA slips from record as Visa and banks weigh after CPI
Next Story

Dow Jones today: DJIA slips from record as Visa and banks weigh after CPI

Go toTop